Min Zhang obtained MD and PhD in Peking University Health Science Centre, China. He then pursued postdoctoral training at King’s College London’s British Heart Foundation (BHF) Centre of Research Excellence. Currently, Dr. Zhang is a BHF Specialist Fellow and Senior Lecturer in Cardiovascular Biology.

Dr. Zhang’s research primarily focuses on elucidating the roles of reactive oxygen species (ROS) and ROS-mediated signaling in various cardiovascular diseases. His work emphasizes the distinct contributions of different NADPH oxidase (NOX) isoforms to cardiac hypertrophy, remodeling, heart failure and aortic valve calcification under pathological conditions, as well as cardiac adaptation in physiological contexts such as exercise. Additionally, he explores active compounds derived from traditional Chinese medicine and their potential therapeutic applications in cardiovascular diseases. He is the Assistant Director of King’s Centre of Integrative Chinese Medicine.

His studies utilize a broad spectrum of techniques ranging from molecular and cell biology and tissue culture to in vivo physiological approaches to investigate the mechanisms underlying adaptive and maladaptive cardiac changes. His goal is to translate these insights into potential therapeutic strategies. Dr. Zhang’s key findings have been published in journals including Journal of the American College of Cardiology (JACC), Circulation, Circulation Research, PNAS, eLife, EMBO Journal, JACC: Basic to Translational Science, and Cardiovascular Research, among others.